12 11, 2020 A successful validation of EasyPGX PIK3CA testing Diatech Pharmacogenetics2020-11-19T14:40:39+01:00 Mehr erfahren
4 11, 2020 NGS: made it Easy with Myriapod Dry! Diatech Pharmacogenetics2020-11-04T16:29:45+01:00 Mehr erfahren
4 11, 2020 EasyPGX ready KRAS together with KRAS G12C inhibitors: one more weapon in the fight against cancer! Diatech Pharmacogenetics2020-11-05T11:15:24+01:00 Mehr erfahren
14 10, 2020 Federica Bertolini et. al., Second Primary Tumors in head and neck cancer patients: the importance of a “tailored” surveillance Diatech Pharmacogenetics2020-11-03T11:53:39+01:00 Mehr erfahren
1 10, 2020 Test auf DPD-Mangel – neue Leistung im EBM Diatech Pharmacogenetics2020-11-04T10:17:43+01:00 Mehr erfahren
28 09, 2020 Alpelisib and PIK3CA mutations: a new molecular targeted therapy for breast cancer is approved Diatech Pharmacogenetics2020-09-28T18:43:55+02:00 Mehr erfahren
28 09, 2020 Francesco Cortiula et. al., A Multi-Center, Real-Life Experience on Liquid Biopsy Practice for EGFR Testing in Non-Small Cell Lung Cancer (NSCLC) Patients Diatech Pharmacogenetics2020-11-03T11:56:51+01:00 Mehr erfahren
9 09, 2020 Magda Zanelli et. al., Acute Radiation Colitis after Preoperative Short-Course Radiotherapy for Rectal Cancer: A Morphological, Immunohistochemical and Genetic Study Diatech Pharmacogenetics2020-11-03T12:02:43+01:00 Mehr erfahren
4 09, 2020 Pierina Navarria et. al., Is IDH status the only factor predicting prognosis in newly diagnosed anaplastic glioma patients? Outcome evaluation and prognostic factor analysis in a single-institution large series Diatech Pharmacogenetics2020-09-04T13:57:59+02:00 Mehr erfahren
1 09, 2020 Umberto Malapelle et. al., Impact of Pre-Analytical Factors on MSI Test Accuracy in Mucinous Colorectal Adenocarcinoma: A Multi-Assay Concordance Study. Diatech Pharmacogenetics2020-11-03T16:41:14+01:00 Mehr erfahren
